A high absolute value of the zeta potential means high

surface charge of the nanoparticles. The zeta potential distribution of the PTX-loaded star-shaped CA-PLA-TPGS nanoparticles MK-4827 research buy is displayed in Figure 2B. As displayed in Table 1, the zeta potential of the PTX-loaded CA-PLA-TPGS nanoparticles and the PLA-TPGS nanoparticles was determined to be -13.0 and -19.3 mV, respectively, which is slightly higher than that of the PLGA nanoparticles of zeta potential about -22.8 mV. The negative surface charge of the nanoparticles may be due to the presence of ionized carboxyl groups of PLA and PGA segments [28]. It can also be found from Table 1 that the contents of drug loading and entrapment efficiency of the CA-PLA-TPGS nanoparticles were higher than those of the PLA-TPGS nanoparticles and the PLGA nanoparticles, indicating the higher binding affinity between the star-shaped core region

find more PLGA and hydrophobic PTX. Moreover, the drug loading content of PTX in the CA-PLA-TPGS nanoparticles could reach approximately 10.0% which is ideal for an efficient drug delivery vehicle. After redispersion in PBS, the mean size and size distribution of the PTX-loaded nanoparticles were nearly not changed during the 3 months of follow-up, suggesting that the PTX-loaded nanoparticles had good stability and redispersion ability. Stability of PTX-loaded nanoparticles In biomedical applications, nanoparticles have to be hydrophilic and maintain a superior stability in biological media. Hydrophilic PEG has been the focus of research as an effective coating material

for hydrophobic nanoparticles due to its ability to resist protein fouling and provide steric hindrance GDC-0068 ic50 preventing nanoparticles from aggregation [34]. In this research, TPGS is a water-soluble PEG derivative of the natural form of d-α-tocopherol, which may play an important role in ensuring nanoparticle stability. During the storage of the nanoformulation, the absolute value of the zeta potential usually becomes low and the nanoparticles become aggregated, so the size distribution was uneven and the nanoparticles are not so suitable for therapy as the fresh nanoparticles. Thus, we measure the average size and size distribution and the zeta potential Nintedanib (BIBF 1120) of PTX-loaded CA-PLA-TPGS nanoparticles stored at 4°C at days 7, 14, 28, 42, 56, 70, and 90 after the formulation of the nanoparticles. As shown in Figure 4, the size (Figure 4A) and zeta potential (Figure 4B) were not obviously changed at 4°C after 3-month storage, which means that PTX-loaded CA-PLA-TPGS nanoparticles are very stable. Figure 4 In vitro stability of the PTX-loaded nanoparticles. (A) The size distribution of PTX-loaded PLGA, PLA-TPGS, and CA-PLA-TPGS NPs for 90-day storage at 4°C. (B) The zeta potential of PTX-loaded PLGA, PLA-TPGS, and CA-PLA-TPGS NPs for 90-day storage at 4°C. In vitro drug release assay The in vitro drug release profiles of the PTX-loaded nanoparticles in PBS (containing 0.1% w/v Tween 80, pH 7.